technewslit, 7 months ago Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds A developer of synthetic antibodies for neurodegenerative disorders delivered like gene therapies is raising €129 million ($US 138 million) in its first venture funding round. https://sciencebusiness.technewslit.com/?p=45398 #News #Press #Science #Business #Biotechnology #ALS #Neuroscience #Neurons #GeneTherapy #Antibodies #Finance #Investment #VentureCapital #Netherlands
Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds
A developer of synthetic antibodies for neurodegenerative disorders delivered like gene therapies is raising €129 million ($US 138 million) in its first venture funding round.
https://sciencebusiness.technewslit.com/?p=45398
#News #Press #Science #Business #Biotechnology #ALS #Neuroscience #Neurons #GeneTherapy #Antibodies #Finance #Investment #VentureCapital #Netherlands